How have PDP shares performed in 2024?

Pediapharm's stock was trading at C$0.30 at the start of the year. Since then, PDP stock has increased by 0.0% and is now trading at C$0.30. View the best growth stocks for 2024 here .

Is Pediapharm a good dividend stock?

Pediapharm (CVE:PDP) pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Pediapharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediapharm investors own include eMagin (EMAN) , Eleven Biotherapeutics (EBIO) , Coro Mining (COP) , Champion Iron (CIA) , Anavex Life Sciences (AVXL) , AVEO Pharmaceuticals (AVEO) , Asterias Biotherapeutics (AST) and Apellis Pharmaceuticals (APLS) .

How do I buy shares of Pediapharm?

Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:PDP

Pediapharm (PDP) Stock Price, News & Analysis

→ Nerd Investor Reveals Secret To Make Money With A.I. (From InvestorPlace) (Ad)

Free PDP Stock Alerts

C$0.30

+0.01 (+1.69%)

(As of 12/18/2018)

Compare

Today's Range: C$0.29
▼
C$0.31
50-Day Range: C$0.30
▼
C$0.30
52-Week Range: C$0.25
▼
C$0.49

Volume: 26,000 shs
Average Volume: 100,369 shs
Market Capitalization: C$66.36 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Pediapharm alerts:

Ad Porter & Company

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.

About Pediapharm Stock (CVE:PDP)

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

PDP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PDP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:PDP
CUSIP: N/A
CIK: N/A
Web: www.pedia-pharm.com
Phone: +1-514-7622626
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 30.00
P/E Growth: 150
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 186.87
Current Ratio: 1.12
Quick Ratio: 0.71

Sales & Book Value

Annual Sales: C$11.16 million
Price / Sales: 5.95
Cash Flow: C$0.01 per share
Price / Cash Flow: 23.08
Book Value: C($0.01) per share
Price / Book: -23.08

Miscellaneous

Outstanding Shares: 221,194,000
Free Float: N/A
Market Cap: C$66.36 million
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Sylvain Chretien (Age 54)
Pres, CEO & Director
Mr. Roland Boivin
Chief Financial Officer
Mr. Richard Labelle
VP of Sales & Marketing
Mr. Benoît Hébert (Age 50)
VP of Bus. Devel. & Licensing
Mr. Normand Chartrand (Age 59)
Consultant

Key Competitors

View All Competitors

PDP Stock Analysis - Frequently Asked Questions

How have PDP shares performed in 2024?: Pediapharm's stock was trading at C$0.30 at the start of the year. Since then, PDP stock has increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2024 here.
Is Pediapharm a good dividend stock?: Pediapharm (CVE:PDP) pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%.
What other stocks do shareholders of Pediapharm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pediapharm investors own include eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP), Champion Iron (CIA), Anavex Life Sciences (AVXL), AVEO Pharmaceuticals (AVEO), Asterias Biotherapeutics (AST) and Apellis Pharmaceuticals (APLS).
How do I buy shares of Pediapharm?: Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:PDP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial